SE0500020L - Topiska kompositioner - Google Patents

Topiska kompositioner

Info

Publication number
SE0500020L
SE0500020L SE0500020A SE0500020A SE0500020L SE 0500020 L SE0500020 L SE 0500020L SE 0500020 A SE0500020 A SE 0500020A SE 0500020 A SE0500020 A SE 0500020A SE 0500020 L SE0500020 L SE 0500020L
Authority
SE
Sweden
Prior art keywords
stasis
well
dermatitis
uridine
eczema
Prior art date
Application number
SE0500020A
Other languages
English (en)
Other versions
SE0500020D0 (sv
SE529064C2 (sv
Inventor
Srinivas Uppugunduri
Original Assignee
Selectica Pharmaceuticals Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Selectica Pharmaceuticals Ab filed Critical Selectica Pharmaceuticals Ab
Priority to SE0500020A priority Critical patent/SE529064C2/sv
Publication of SE0500020D0 publication Critical patent/SE0500020D0/sv
Priority to PCT/SE2006/000008 priority patent/WO2006073359A1/en
Priority to AU2006204184A priority patent/AU2006204184A1/en
Priority to EP06700061A priority patent/EP1833491A4/en
Publication of SE0500020L publication Critical patent/SE0500020L/sv
Publication of SE529064C2 publication Critical patent/SE529064C2/sv
Priority to US11/768,438 priority patent/US20080004235A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SE0500020A 2005-01-03 2005-01-03 Topiska kompositioner SE529064C2 (sv)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE0500020A SE529064C2 (sv) 2005-01-03 2005-01-03 Topiska kompositioner
PCT/SE2006/000008 WO2006073359A1 (en) 2005-01-03 2006-01-02 Topical compositions comprising one or more of 44-thiouridine, isomaltitol and uridine
AU2006204184A AU2006204184A1 (en) 2005-01-03 2006-01-02 Topical compositions comprising one or more of 4-thiouridine, isomaltitol and uridine
EP06700061A EP1833491A4 (en) 2005-01-03 2006-01-02 TOPICAL COMPOSITIONS WITH ONE OR MORE 44-THIURIDINE, ISOMALTITOL AND URIDINE
US11/768,438 US20080004235A1 (en) 2005-01-03 2007-06-26 Topical compositions comprising one or more of 4-thiouridine, isomaltitol and uridine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0500020A SE529064C2 (sv) 2005-01-03 2005-01-03 Topiska kompositioner

Publications (3)

Publication Number Publication Date
SE0500020D0 SE0500020D0 (sv) 2005-01-03
SE0500020L true SE0500020L (sv) 2006-07-04
SE529064C2 SE529064C2 (sv) 2007-04-24

Family

ID=34132496

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0500020A SE529064C2 (sv) 2005-01-03 2005-01-03 Topiska kompositioner

Country Status (5)

Country Link
US (1) US20080004235A1 (sv)
EP (1) EP1833491A4 (sv)
AU (1) AU2006204184A1 (sv)
SE (1) SE529064C2 (sv)
WO (1) WO2006073359A1 (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8410125B2 (en) 2007-11-05 2013-04-02 Yagna Limited Sulfonated precursors of thymidine for the treatment of epithelial hyperplasias
EP2637635A1 (de) * 2010-11-12 2013-09-18 La Prairie Group AG Kosmetische und/oder dermatologische zubereitungen enthaltend schneealgenextrakt

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1324703A (en) * 1969-07-17 1973-07-25 Schering Ag Externally applicable pharmaceutical preparations for treating psoriasis vulgaris and malign skin tumours
JPH07215879A (ja) * 1994-02-02 1995-08-15 Otsuka Pharmaceut Factory Inc 抗ストレス組成物
JP4408450B2 (ja) * 1994-07-01 2010-02-03 ウェルスタット セラピューティクス コーポレイション 全身性炎症および炎症性肝炎の処置のためのピリミジンヌクレオチド前駆体
SE9701219D0 (sv) * 1997-04-04 1997-04-04 Astra Pharma Prod New compounds
AU8388198A (en) * 1997-08-21 1999-03-08 Basf Aktiengesellschaft Use of uridine to counter 5-fluorouracil toxicity
SE521031C2 (sv) * 1999-05-05 2003-09-23 Srinivas Uppugunduri Nya specifika inhibitorer av akut och kronisk inflammation
US7361643B2 (en) * 2000-02-09 2008-04-22 University Of Puerto Rico Methods for inhibiting angiogenesis
KR20050043761A (ko) * 2001-11-06 2005-05-11 인스파이어 파마슈티컬스 인코퍼레이티드 염증성 질환의 치료 또는 예방 방법
KR100977475B1 (ko) * 2004-05-21 2010-08-23 주식회사 머젠스 히아루론산, 글리코사미노글리칸 및/또는 콜라겐의생합성을 촉진하는 우리딘 및 우리딘 유도체

Also Published As

Publication number Publication date
AU2006204184A1 (en) 2006-07-13
SE0500020D0 (sv) 2005-01-03
EP1833491A1 (en) 2007-09-19
EP1833491A4 (en) 2010-01-13
US20080004235A1 (en) 2008-01-03
WO2006073359A1 (en) 2006-07-13
SE529064C2 (sv) 2007-04-24

Similar Documents

Publication Publication Date Title
HRP20040917B1 (hr) Topiäśki farmaceutski pripravci koji sadrže proantocijanide za tretman dermatitisa
WO2010063996A3 (en) Antibacterial compounds
WO2010090860A3 (en) Methods and compositions for treating bacterial infection
WO2005072826A3 (en) Compositions and use of tyrosine kinase inhibitors to treat pathogenic infection
EA201270562A1 (ru) Арил- и гетероарилкарбонильные производные гексагидроинденопиридина и октагидробензохинолина
WO2012143796A3 (en) Anti-inflammation compounds
WO2009100406A3 (en) Topical formulations for the treatment of psoriasis
BR112012018170B8 (pt) agente antimicrobiano para redução, inibição ou tratamento do crescimento microbiano, infecções microbianas, doenças inflamatórias, doenças ou condições virais resultantes de ou associadas aos mesmos
WO2007109230A3 (en) Nutrient compositions for the treatment and prevention of inflammation and disorders associated therewith
EA201301040A1 (ru) Гетероциклическое соединение и его применение
WO2006093547A3 (en) Novel lipoxygenase inhibitors
BR112014026058A2 (pt) composições para tratamento tópico de infecções microbianas
WO2009061916A3 (en) Benzodiazepinone compounds useful in the treatment of skin conditions
EA200901289A1 (ru) Композиции и способы для противовосполительного лечения
UA109557C2 (uk) Похідні 2-піперазин-1-іл-4h-1,3-бензотіазин-4-ону та їх застосування для лікування інфекцій у ссавців
AU2009319796A8 (en) Substituted octahydrocyclopnta (c) pyrrol-4 -amines as calcium channel blockers
PE20141410A1 (es) 3,4 dihidro 1h[1,8] naftiridinonas antibacterianas sustituidas con ciclopenta [c] pirrol
NO20092655L (no) 2-kinolinon- og 2-kinoksalinonderivater og deres anvendelse som antibakterielle midler
MX2010007810A (es) Coposicion que contiene capsicum para tratar un trastorno de la piel.
WO2011119247A3 (en) Topical skincare composition
MA32375B1 (fr) Derives de 5-hydroxymethyl-oxazolidine-2-one pour le traitement de maladies intestinales bacteriennes
MX2012014163A (es) Uso de acido sialico, precursor de acido sialico o una combinacion de los anteriores para preparar medicamentos utiles en una condicion diabetica o sindrome nefrotico.
DK1971608T3 (da) Spiroketaler
ATE402924T1 (de) Pyridiniumsalze und deren verwendung
SE0500020D0 (sv) Topical compositions

Legal Events

Date Code Title Description
NUG Patent has lapsed